PubMed:26402627
Annnotations
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 26402627-0#22#26#gene627 | 22-26 | gene627 | denotes | BDNF |
| 26402627-0#6#17#diseaseC0002726 | 6-17 | diseaseC0002726 | denotes | Amyloidosis |
| 26402627-3#169#202#gene627 | 518-551 | gene627 | denotes | brain-derived neurotrophic factor |
| 26402627-3#204#208#gene627 | 553-557 | gene627 | denotes | BDNF |
| 26402627-3#125#139#diseaseC0333463 | 474-488 | diseaseC0333463 | denotes | amyloid plaque |
| 26402627-3#125#139#diseaseC2936349 | 474-488 | diseaseC2936349 | denotes | amyloid plaque |
| 26402627-3#125#139#diseaseC0333463 | 474-488 | diseaseC0333463 | denotes | amyloid plaque |
| 26402627-3#125#139#diseaseC2936349 | 474-488 | diseaseC2936349 | denotes | amyloid plaque |
| 22#26#gene6276#17#diseaseC0002726 | 26402627-0#22#26#gene627 | 26402627-0#6#17#diseaseC0002726 | associated_with | BDNF,Amyloidosis |
| 169#202#gene627125#139#diseaseC0333463 | 26402627-3#169#202#gene627 | 26402627-3#125#139#diseaseC0333463 | associated_with | brain-derived neurotrophic factor,amyloid plaque |
| 169#202#gene627125#139#diseaseC2936349 | 26402627-3#169#202#gene627 | 26402627-3#125#139#diseaseC2936349 | associated_with | brain-derived neurotrophic factor,amyloid plaque |
| 169#202#gene627125#139#diseaseC0333463 | 26402627-3#169#202#gene627 | 26402627-3#125#139#diseaseC0333463 | associated_with | brain-derived neurotrophic factor,amyloid plaque |
| 169#202#gene627125#139#diseaseC2936349 | 26402627-3#169#202#gene627 | 26402627-3#125#139#diseaseC2936349 | associated_with | brain-derived neurotrophic factor,amyloid plaque |
| 204#208#gene627125#139#diseaseC0333463 | 26402627-3#204#208#gene627 | 26402627-3#125#139#diseaseC0333463 | associated_with | BDNF,amyloid plaque |
| 204#208#gene627125#139#diseaseC2936349 | 26402627-3#204#208#gene627 | 26402627-3#125#139#diseaseC2936349 | associated_with | BDNF,amyloid plaque |
| 204#208#gene627125#139#diseaseC0333463 | 26402627-3#204#208#gene627 | 26402627-3#125#139#diseaseC0333463 | associated_with | BDNF,amyloid plaque |
| 204#208#gene627125#139#diseaseC2936349 | 26402627-3#204#208#gene627 | 26402627-3#125#139#diseaseC2936349 | associated_with | BDNF,amyloid plaque |
DisGeNet-2017-sample
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1666 | 518-551 | gene:627 | denotes | brain-derived neurotrophic factor |
| T1667 | 474-488 | disease:C0333463 | denotes | amyloid plaque |
| T1668 | 553-557 | gene:627 | denotes | BDNF |
| R1 | T1666 | T1667 | associated_with | brain-derived neurotrophic factor,amyloid plaque |
| R2 | T1666 | T1667 | associated_with | brain-derived neurotrophic factor,amyloid plaque |
| R3 | T1668 | T1667 | associated_with | BDNF,amyloid plaque |
| R4 | T1668 | T1667 | associated_with | BDNF,amyloid plaque |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-119 | Sentence | denotes | Brain Amyloidosis and BDNF Deficiency Have Opposite Effects on Brain Volumes in AβPP/PS1 Mice Both in vivo and ex vivo. |
| TextSentencer_T2 | 120-261 | Sentence | denotes | Magnetic resonance imaging (MRI) volumetry is widely used in Alzheimer's disease (AD) research and diagnostics alongside clinical assessment. |
| TextSentencer_T3 | 262-348 | Sentence | denotes | Yet few MRI volumetry studies have been conducted in AD model mice with mixed results. |
| TextSentencer_T4 | 349-568 | Sentence | denotes | We performed in vivo and ex vivo MRI and extensive postmortem histological analysis in transgenic mice derived from crossing amyloid plaque producing AβPP/PS1 mice with brain-derived neurotrophic factor (BDNF) +/- mice. |
| TextSentencer_T5 | 569-705 | Sentence | denotes | This allowed us to compare developmental volumetric changes due to BDNF deficiency with progressive changes due to amyloid accumulation. |
| TextSentencer_T6 | 706-913 | Sentence | denotes | We found decreased whole brain volume at 3 months and decreased cortical volume at both 3 and 8 months in vivo in BDNF +/- Tg mice but increased whole brain and cortical volumes at 8 months in AβPP/PS1 mice. |
| TextSentencer_T7 | 914-1063 | Sentence | denotes | Consistent with this, the postmortem histological analysis showed decreased brain parenchymal area in BDNF +/- mice but an increase in AβPP/PS1 mice. |
| TextSentencer_T8 | 1064-1284 | Sentence | denotes | BDNF gene deficiency did not affect brain amyloid load or astrogliosis, but led to decreased dentate gyrus length, whereas AβPP/PS1 mice had significantly increased amyloid load, astrogliosis, and decreased neurogenesis. |
| TextSentencer_T9 | 1285-1381 | Sentence | denotes | Distinct and layer-specific effects were found in the hippocampus of AβPP/PS1 and BDNF +/- mice. |
| TextSentencer_T10 | 1382-1565 | Sentence | denotes | In contrast to human AD patients, brain atrophy in amyloid producing mice appears to be masked by volume increase due to amyloid accumulation and especially accompanying astrogliosis. |
| TextSentencer_T11 | 1566-1709 | Sentence | denotes | Our results indicate that cortical MRI volumetry can be used to some extent as a proxy to progressive brain amyloidosis in preclinical studies. |
| T1 | 0-119 | Sentence | denotes | Brain Amyloidosis and BDNF Deficiency Have Opposite Effects on Brain Volumes in AβPP/PS1 Mice Both in vivo and ex vivo. |
| T2 | 120-261 | Sentence | denotes | Magnetic resonance imaging (MRI) volumetry is widely used in Alzheimer's disease (AD) research and diagnostics alongside clinical assessment. |
| T3 | 262-348 | Sentence | denotes | Yet few MRI volumetry studies have been conducted in AD model mice with mixed results. |
| T4 | 349-568 | Sentence | denotes | We performed in vivo and ex vivo MRI and extensive postmortem histological analysis in transgenic mice derived from crossing amyloid plaque producing AβPP/PS1 mice with brain-derived neurotrophic factor (BDNF) +/- mice. |
| T5 | 569-705 | Sentence | denotes | This allowed us to compare developmental volumetric changes due to BDNF deficiency with progressive changes due to amyloid accumulation. |
| T6 | 706-913 | Sentence | denotes | We found decreased whole brain volume at 3 months and decreased cortical volume at both 3 and 8 months in vivo in BDNF +/- Tg mice but increased whole brain and cortical volumes at 8 months in AβPP/PS1 mice. |
| T7 | 914-1063 | Sentence | denotes | Consistent with this, the postmortem histological analysis showed decreased brain parenchymal area in BDNF +/- mice but an increase in AβPP/PS1 mice. |
| T8 | 1064-1284 | Sentence | denotes | BDNF gene deficiency did not affect brain amyloid load or astrogliosis, but led to decreased dentate gyrus length, whereas AβPP/PS1 mice had significantly increased amyloid load, astrogliosis, and decreased neurogenesis. |
| T9 | 1285-1381 | Sentence | denotes | Distinct and layer-specific effects were found in the hippocampus of AβPP/PS1 and BDNF +/- mice. |
| T10 | 1382-1565 | Sentence | denotes | In contrast to human AD patients, brain atrophy in amyloid producing mice appears to be masked by volume increase due to amyloid accumulation and especially accompanying astrogliosis. |
| T11 | 1566-1709 | Sentence | denotes | Our results indicate that cortical MRI volumetry can be used to some extent as a proxy to progressive brain amyloidosis in preclinical studies. |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 0-5 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | Brain |
| PD-UBERON-AE-B_T2 | 63-68 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | Brain |
| PD-UBERON-AE-B_T3 | 518-523 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | brain |
| PD-UBERON-AE-B_T4 | 731-736 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | brain |
| PD-UBERON-AE-B_T5 | 857-862 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | brain |
| PD-UBERON-AE-B_T6 | 990-995 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | brain |
| PD-UBERON-AE-B_T7 | 1100-1105 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | brain |
| PD-UBERON-AE-B_T8 | 1416-1421 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | brain |
| PD-UBERON-AE-B_T9 | 1668-1673 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | brain |
| PD-UBERON-AE-B_T10 | 390-399 | http://purl.obolibrary.org/obo/UBERON_2000106 | denotes | extensive |
| PD-UBERON-AE-B_T11 | 996-1007 | http://purl.obolibrary.org/obo/UBERON_0000353 | denotes | parenchymal |
| PD-UBERON-AE-B_T12 | 1165-1170 | http://purl.obolibrary.org/obo/UBERON_0000200 | denotes | gyrus |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 390-399 | http://purl.obolibrary.org/obo/UBERON_2000106 | denotes | extensive |
| PD-UBERON-AE-B_T2 | 0-5 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | Brain |
| PD-UBERON-AE-B_T3 | 63-68 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | Brain |
| PD-UBERON-AE-B_T4 | 518-523 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | brain |
| PD-UBERON-AE-B_T5 | 731-736 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | brain |
| PD-UBERON-AE-B_T6 | 857-862 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | brain |
| PD-UBERON-AE-B_T7 | 990-995 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | brain |
| PD-UBERON-AE-B_T8 | 1100-1105 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | brain |
| PD-UBERON-AE-B_T9 | 1416-1421 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | brain |
| PD-UBERON-AE-B_T10 | 1668-1673 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | brain |
| PD-UBERON-AE-B_T11 | 996-1007 | http://purl.obolibrary.org/obo/UBERON_0000353 | denotes | parenchymal |
| PD-UBERON-AE-B_T12 | 1165-1170 | http://purl.obolibrary.org/obo/UBERON_0000200 | denotes | gyrus |